HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma.

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma.

Item
http://www.wikidata.org/entity/Q37381593
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas.The Therapeutic Challenge of Targeting HER2 in Endometrial CancerEfficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial.A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer.Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE.Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET).Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
P2860

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma.

Item
http://www.wikidata.org/entity/Q37381593
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HER4 expression status correla ...... ted invasive breast carcinoma.
@en
HER4 expression status correla ...... ted invasive breast carcinoma.
@nl
type
label
HER4 expression status correla ...... ted invasive breast carcinoma.
@en
HER4 expression status correla ...... ted invasive breast carcinoma.
@nl
prefLabel
HER4 expression status correla ...... ted invasive breast carcinoma.
@en
HER4 expression status correla ...... ted invasive breast carcinoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
HER4 expression status correla ...... ted invasive breast carcinoma.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932